Drug Shortage Report for FETZIMA
Report ID | 84779 |
Drug Identification Number | 02440997 |
Brand name | FETZIMA |
Common or Proper name | FETZIMA 80MG CAP 30 CA |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOMILNACIPRAN |
Strength(s) | 80MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | FETZIMA 80MG CAP 30 CA |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2019-05-24 |
Actual start date | 2019-05-24 |
Estimated end date | 2019-06-05 |
Actual end date | 2019-06-06 |
Shortage status | Resolved |
Updated date | 2019-06-07 |
Company comments | Potential issue with the label |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-06-07 | French | Compare |
v11 | 2019-06-06 | English | Compare |
v10 | 2019-06-06 | French | Compare |
v9 | 2019-06-06 | English | Compare |
v8 | 2019-06-06 | French | Compare |
v7 | 2019-06-06 | English | Compare |
v6 | 2019-06-06 | French | Compare |
v5 | 2019-06-06 | English | Compare |
v4 | 2019-05-27 | French | Compare |
v3 | 2019-05-27 | English | Compare |
v2 | 2019-05-25 | French | Compare |
v1 | 2019-05-25 | English | Compare |
Showing 1 to 12 of 12